Beijing Tong Ren Tang Chinese Medicine Company Limited released its monthly return for February 2026. The total number of issued ordinary shares stood at 837.10 million, with no change from the previous month. There were no treasury shares during this period.

The company confirmed that its public float requirement of 25% remained fully compliant. During February 2026, there were no movements related to share options, warrants, convertibles, or other share issuance arrangements, and no changes to the authorized or registered share capital were reported.